vesigentx.com

Vesigen | ARRDC1 Mediated Microvesicles (ARMMs) | Intracellular Therapeutics

Vesigen’s patented technology uses ARRDC1 Mediated Microvesicles (ARMMs) to deliver intracellular therapeutics to previously undruggable targets.

Last seen: March 11th at 1:35am — Visit site